Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PTEN |
Variant | E43fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | PTEN E43fs results in a change in the amino acid sequence of the PTEN protein beginning at aa 43 of 403, likely resulting in premature truncation of the functional protein (UniProt.org). E43fs has not been characterized, however, due to the effects of other truncation mutations downstream of E43 (PMID: 10468583), is predicted to lead to a loss of Pten protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PTEN mutant PTEN inact mut PTEN E43fs |
Transcript | NM_000314.8 |
gDNA | chr10:g.(87894071_87894072) |
cDNA | c.(127_126) |
Protein | p.E43fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000314.8 | chr10:g.(87894071_87894072) | c.(127_126) | p.E43fs | RefSeq | GRCh38/hg38 |
NM_000314.6 | chr10:g.(87894071_87894072) | c.(127_126) | p.E43fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PTEN E43fs | choroid plexus carcinoma | predicted - sensitive | Everolimus | Case Reports/Case Series | Actionable | In a clinical case study, adjuvant Afinitor (everolimus) treatment after surgery and radiotherapy resulted in stable disease in a patient with choroid plexus carcinoma harboring PTEN E43fs, who completed 12 months of therapy and remained in remission at 60 months after initial diagnosis (PMID: 37535883). | 37535883 |